Authors:
Claudel, T
Leibowitz, MD
Fievet, C
Tailleux, A
Wagner, B
Repa, JJ
Torpier, G
Lobaccaro, JM
Paterniti, JR
Mangelsdorf, DJ
Heyman, RA
Auwerx, J
Citation: T. Claudel et al., Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor, P NAS US, 98(5), 2001, pp. 2610-2615
Authors:
Dana, SL
Hoener, PA
Bilakovics, JM
Crombie, DL
Ogilvie, KM
Kauffman, RF
Mukherjee, R
Paterniti, JR
Citation: Sl. Dana et al., Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat, METABOLISM, 50(8), 2001, pp. 963-971
Authors:
Brooks, DA
Etgen, GJ
Rito, CJ
Shuker, AJ
Dominianni, SJ
Warshawsky, AM
Ardecky, R
Paterniti, JR
Tyhonas, J
Karanewsky, DS
Kauffman, RF
Broderick, CL
Oldham, BA
Montrose-Rafizadeh, C
Winneroski, LL
Faul, MM
McCarthy, JR
Citation: Da. Brooks et al., Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: A new class of dual PPAR alpha/gamma agonists, J MED CHEM, 44(13), 2001, pp. 2061-2064
Authors:
Cha, BS
Ciaraldi, TP
Carter, L
Nikoulina, SE
Mudaliar, S
Mukherjee, R
Paterniti, JR
Henry, RR
Citation: Bs. Cha et al., Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle, DIABETOLOG, 44(4), 2001, pp. 444-452
Citation: Jw. Chisholm et al., Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoproteinA-I activation of LCAT, BBA-MOL C B, 1487(2-3), 2000, pp. 145-154